Skip to main content
Top

Current Oncology Reports

Issue 5/2020

Content (13 Articles)

Coronavirus Hot Topic

COVID-19 and Cancer: a Comprehensive Review

Rohit Gosain, Yara Abdou, Abhay Singh, Navpreet Rana, Igor Puzanov, Marc S. Ernstoff

NSCLC Lung Cancer (H Borghaei, Section Editor)

Hyperprogressive Disease upon Immune Checkpoint Blockade: Focus on Non–small Cell Lung Cancer

Giuseppe Lo Russo, Francesco Facchinetti, Marcello Tiseo, Marina Chiara Garassino, Roberto Ferrara

NSCLC Lung Cancer (H Borghaei, Section Editor)

New Targets in Lung Cancer (Excluding EGFR, ALK, ROS1)

Alessandro Russo, Ana Rita Lopes, Michael G. McCusker, Sandra Gimenez Garrigues, Giuseppina R. Ricciardi, Katherine E. Arensmeyer, Katherine A. Scilla, Ranee Mehra, Christian Rolfo

Cytostatic Therapy Palliative Medicine (A Jatoi, Section Editor)

The Physical Consequences of Chemotherapy-Induced Peripheral Neuropathy

Cindy S. Tofthagen, Andrea L. Cheville, Charles L. Loprinzi

Liver Transplantation Gastrointestinal Cancers (J Meyer, Section Editor)

Liver Transplantation for Cholangiocarcinoma: Insights into the Prognosis and the Evolving Indications

Guergana G. Panayotova, Flavio Paterno, James V. Guarrera, Keri E. Lunsford

Magnetic Resonance Imaging Gastrointestinal Cancers (J Meyer, Section Editor)

Updates on Imaging of Liver Tumors

Arya Haj-Mirzaian, Ana Kadivar, Ihab R. Kamel, Atif Zaheer

Rituximab Lymphomas (MR Smith, Section Editor)

Hairy Cell Leukaemia

Matthew Cross, Claire Dearden

Lymphoma Lymphomas (MR Smith, Section Editor)

Therapy of Peripheral T Cell Lymphoma: Focus on Nodal Subtypes

Pamela B. Allen, Barbara Pro

Interventional Oncology (DC Madoff, Section Editor)

Percutaneous Management of Cancer Pain

Dimitrios K. Filippiadis, Lambros Tselikas, Alberto Bazzocchi, Evegnia Efthymiou, Alexis Kelekis, Steven Yevich

Care Neuro-oncology (Y Umemura, Section Editor)

Developing Real-world Evidence-Ready Datasets: Time for Clinician Engagement

James M. Snyder, Jacob A. Pawloski, Laila M. Poisson

Breast Cancer Breast Cancer (B Overmoyer, Section Editor)

Applying the New Guidelines of HER2 Testing in Breast Cancer

Huina Zhang, Ioana Moisini, Rana M. Ajabnoor, Bradley M. Turner, David G. Hicks

Glioma Correction

Correction to: Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma

Kyle Wierzbicki, Karthik Ravi, Andrea Franson, Amy Bruzek, Evan Cantor, Micah Harris, Morgan J. Homan, Bernard L. Marini, Abed Rahman Kawakibi, Ramya Ravindran, Rodrigo Teodoro, Viveka Nand Yadav, Carl Koschmann

NSCLC Correction

Correction to: The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring

Jillian Wilhelmina Paulina Bracht, Clara Mayo-de-las-Casas, Jordi Berenguer, Niki Karachaliou, Rafael Rosell

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine